Patients With Implantable Cardiac Devices Requiring a Nuclear Magnetic Resonance

NCT ID: NCT04330898

Last Updated: 2020-04-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

1248 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-05-02

Study Completion Date

2020-07-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The general objective of this registry is to study the number of patients carrying an implantable cardiac device that have an indication for an imaging diagnosis based on nuclear magnetic resonance. Is wanted to know the cause of the indication of the diagnostic test based on MRI.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

MRI is currently infra indicated in patients with cardiac stimulation devices and for this reason, the request for this imaging technique in these patients is complicated and, often, the MRI-based test is replaced by a CT scan that may not be so beneficial for the diagnosis.

Current data indicate that, with cardiological control and maintaining basic safety precautions, MRI could be performed in patients with peacemakers and Implantable Cardioverter Defibrillators (ICD) that require it for clinical reasons, although it should be noted that currently, due to lack of data published, the absolute safety of an MRI in these patients and the protocol used in each case cannot be guaranteed.

This registry proposal is to have data of all patients implanted with Biotronik cardiac stimulation devices and evaluate how many of them have an indication for an MRI-based diagnostic test, how many of them are already undergoing this diagnostic test, how many are given an tomography as an alternative to avoid subjecting patients to an MRI

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Implantable Cardiac Device. Patients With a NMR Indication

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Biotronik peacemakers, implantable cardioverter-defibrillators and cardiac resynchronizers

Any of these Biotronik cardiac stimulation devices with the Home Monitoring function activated for the remote control of patients

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients carrying a cardiac stimulation device
* Patients able to understand the nature of the procedure
* Patients who give informed consent

Exclusion Criteria

* Epicardial cables
* Abandoned cables
* Non-BIOTRONIK cables
* Age \<18 years
* Pregnant and breastfeeding
* Subjects with irreversible brain damage caused by a pre-existing brain disease
* Heart transplant 6 months prior to recruitment or expected within the next 3 months
* Cardiac surgery 3 months prior to recruitment or planned for the next 3 months
* Life expectancy less than 12 months
Minimum Eligible Age

19 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Trialance SCCL

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Francisco Javier Alzueta, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Hospital Virgen de la Victoria

Francisco Ruiz Mateas, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Hospital Costa del Sol

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hospital San Pedro de Alcantara

Cáceres, Madrid, Spain

Site Status RECRUITING

Hospital de Poniente

El Ejido, Madrid, Spain

Site Status RECRUITING

Hospital Arquitecto Marcide

Ferrol, Madrid, Spain

Site Status RECRUITING

Hospital de Galdakano

Galdakao, Madrid, Spain

Site Status RECRUITING

Hospital de Orense

Orense, Madrid, Spain

Site Status RECRUITING

Hospital General de Asturias

Oviedo, Madrid, Spain

Site Status RECRUITING

Hospital Virgen del Puerto

Plasencia, Madrid, Spain

Site Status NOT_YET_RECRUITING

Hospital de Puerto Real

Puerto Real, Madrid, Spain

Site Status RECRUITING

Hospital Parc Taul'i

Sabadell, Madrid, Spain

Site Status RECRUITING

Hospital Marques de Valdecilla

Santander, Madrid, Spain

Site Status RECRUITING

Hospital Rio Hortega

Valladolid, Madrid, Spain

Site Status RECRUITING

Hospital Universitatis de Araba

Vitoria, Madrid, Spain

Site Status RECRUITING

Hospital General de Alicante

Alicante, , Spain

Site Status RECRUITING

Hospital San Juan de Alicante

Alicante, , Spain

Site Status RECRUITING

Hospital de Cruces

Barakaldo, , Spain

Site Status RECRUITING

Hospital Clinic

Barcelona, , Spain

Site Status RECRUITING

Hospital de Bellvitge

Barcelona, , Spain

Site Status RECRUITING

Hospital Puerta de Hierro

Madrid, , Spain

Site Status RECRUITING

Hospital Costa del Sol

Marbella, , Spain

Site Status RECRUITING

Hospital Virgen de la Victoria

Málaga, , Spain

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Spain

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Xavier Molina Figueras, PharmD, PhD

Role: CONTACT

+ 34 689900009

Marta Barbacid Hernández, PharmD, MSc

Role: CONTACT

+34 630767668

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Marta Barbacid Hernández, PharmD, MSc

Role: primary

+34630767668

Concetta Chirico, PharmTechD

Role: backup

+34645494281

Marta B Barbacid Hernández, PharmD, MSc

Role: primary

+34630767668

Concetta Chirico, PharmTechD

Role: backup

+34645494281

Marta Barbacid Hernández, PharmD, MSc

Role: primary

+34630767668

Concetta Chirico, PharmTechD

Role: backup

+34645494281

Marta Barbacid Hernández, PharmD, MSc

Role: primary

+34630767668

Concetta B Chirico, PharmD, MSc

Role: backup

+34645494281

Marta Barbacid Hernández, PharmD, MSc

Role: primary

+34630767668

Concetta Chirico, PharmTechD

Role: backup

+34645494281

Marta Barbacid Hernández, PharmD, MSc

Role: primary

+34630767668

Concetta Chirico, PharmTechD

Role: backup

+34645494281

Marta Barbacid Hernández, PharmD, MSc

Role: primary

+34630767668

Concetta Chirico, PharmTechD

Role: backup

+34645494281

Marta Barbacid Hernández, ParmD, MSc

Role: primary

+34630767668

Concetta Chirico, PharmTechD

Role: backup

+34645494281

Marta B Barbacid Hernández, PharmD, MSc

Role: primary

+34630767668

Concetta Chirico, PharmTechD

Role: backup

+34645494281

Marta Barbacid Hernández, PharmD, MSc

Role: primary

+34630767668

Concetta Chirico, PharmTechD

Role: backup

+34645494981cchiric

Marta Barbacid Hernández, PharmD, MSc

Role: primary

+34630767668

Concetta Chirico, PharmTechD

Role: backup

+34645494281

Marta Barbacid Hernández, PharmD, MSc

Role: primary

+34630767668

Concetta Chirico, PharmTechD

Role: backup

+34645494281

Concetta Chirico, PharmTechD

Role: primary

+34645494281

Marta Barbacid Hernández, PhrmD, MSc

Role: backup

+34630767668

Concetta Chirico, PharmTechD

Role: primary

+34645494281

Marta Barbacid Hernández, PharmD,MSc

Role: backup

+34630767668

Marta Barbacid Hernández, PharmD, MSc

Role: primary

+34630767668

Concetta Chirico, PhamTechD

Role: backup

+34645494281

Concetta Chirico, PharmTechD

Role: primary

+34645494281

Marta Barbacid Hernández, PharmD, MSc

Role: backup

+34630767668

Concetta Chirico, PharmTechD

Role: primary

+34645494281

Marta Barbacid Hernández, PharmD, MSc

Role: backup

+34630767668

Marta Barbacid Hernández, PharmD, MSc

Role: primary

+34630767668

Concetta Chirirco, PharmTechD

Role: backup

+34645494281

Concetta Chirico, PharmTechD

Role: primary

+34645494281

Marta Barbacid Hernández, PharmD, MSc

Role: backup

+34630767668

Concetta Chirico, PharmTechD

Role: primary

+34 645494281

Marta Barbacid, PharmD, MSc

Role: backup

+34 630767668

References

Explore related publications, articles, or registry entries linked to this study.

Marcu CB, Beek AM, van Rossum AC. Clinical applications of cardiovascular magnetic resonance imaging. CMAJ. 2006 Oct 10;175(8):911-7. doi: 10.1503/cmaj.060566.

Reference Type BACKGROUND
PMID: 17030942 (View on PubMed)

Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. Am J Med. 1994 Mar;96(3):200-9. doi: 10.1016/0002-9343(94)90143-0.

Reference Type BACKGROUND
PMID: 8154507 (View on PubMed)

Kanal E, Borgstede JP, Barkovich AJ, Bell C, Bradley WG, Etheridge S, Felmlee JP, Froelich JW, Hayden J, Kaminski EM, Lester JW Jr, Scoumis EA, Zaremba LA, Zinninger MD; American College of Radiology. American College of Radiology White Paper on MR Safety: 2004 update and revisions. AJR Am J Roentgenol. 2004 May;182(5):1111-4. doi: 10.2214/ajr.182.5.1821111. No abstract available.

Reference Type BACKGROUND
PMID: 15100103 (View on PubMed)

Gold MR, Sommer T, Schwitter J, Al Fagih A, Albert T, Merkely B, Peterson M, Ciuffo A, Lee S, Landborg L, Cerkvenik J, Kanal E; Evera MRI Study Investigators. Full-Body MRI in Patients With an Implantable Cardioverter-Defibrillator: Primary Results of a Randomized Study. J Am Coll Cardiol. 2015 Jun 23;65(24):2581-2588. doi: 10.1016/j.jacc.2015.04.047. Epub 2015 May 14.

Reference Type RESULT
PMID: 25982014 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

RMN01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

3T MRI CIED Post-Approval Study
NCT02969395 COMPLETED
ProMRI PROVEN Master Study
NCT01809665 COMPLETED
PANORAMA Observational Study
NCT00382525 COMPLETED